These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15509507)

  • 1. Sustained phenotypic correction of hemophilia a mice following oncoretroviral-mediated expression of a bioengineered human factor VIII gene in long-term hematopoietic repopulating cells.
    Moayeri M; Ramezani A; Morgan RA; Hawley TS; Hawley RG
    Mol Ther; 2004 Nov; 10(5):892-902. PubMed ID: 15509507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction of murine hemophilia A by hematopoietic stem cell gene therapy.
    Moayeri M; Hawley TS; Hawley RG
    Mol Ther; 2005 Dec; 12(6):1034-42. PubMed ID: 16226058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow mesenchymal cells for haemophilia A gene therapy using retroviral vectors with modified long-terminal repeats.
    Van Damme A; Chuah MK; Dell'accio F; De Bari C; Luyten F; Collen D; VandenDriessche T
    Haemophilia; 2003 Jan; 9(1):94-103. PubMed ID: 12558785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical Development of a Hematopoietic Stem and Progenitor Cell Bioengineered Factor VIII Lentiviral Vector Gene Therapy for Hemophilia A.
    Doering CB; Denning G; Shields JE; Fine EJ; Parker ET; Srivastava A; Lollar P; Spencer HT
    Hum Gene Ther; 2018 Oct; 29(10):1183-1201. PubMed ID: 30160169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor VIII delivered by haematopoietic stem cell-derived B cells corrects the phenotype of haemophilia A mice.
    Ramezani A; Zweier-Renn LA; Hawley RG
    Thromb Haemost; 2011 Apr; 105(4):676-87. PubMed ID: 21264447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction of murine hemophilia A following nonmyeloablative transplantation of hematopoietic stem cells engineered to encode an enhanced human factor VIII variant using a safety-augmented retroviral vector.
    Ramezani A; Hawley RG
    Blood; 2009 Jul; 114(3):526-34. PubMed ID: 19470695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient lentiviral transduction and improved engraftment of human bone marrow mesenchymal cells.
    Van Damme A; Thorrez L; Ma L; Vandenburgh H; Eyckmans J; Dell'Accio F; De Bari C; Luyten F; Lillicrap D; Collen D; VandenDriessche T; Chuah MK
    Stem Cells; 2006 Apr; 24(4):896-907. PubMed ID: 16339997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo transduction of hematopoietic stem cells after neonatal intravenous injection of an amphotropic retroviral vector in mice.
    Xu L; O'Malley T; Sands MS; Wang B; Meyerrose T; Haskins ME; Ponder KP
    Mol Ther; 2004 Jul; 10(1):37-44. PubMed ID: 15233940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simplified retroviral vector gcsap with murine stem cell virus long terminal repeat allows high and continued expression of enhanced green fluorescent protein by human hematopoietic progenitors engrafted in nonobese diabetic/severe combined immunodeficient mice.
    Kaneko S; Onodera M; Fujiki Y; Nagasawa T; Nakauchi H
    Hum Gene Ther; 2001 Jan; 12(1):35-44. PubMed ID: 11177540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentivirus-mediated platelet gene therapy of murine hemophilia A with pre-existing anti-factor VIII immunity.
    Kuether EL; Schroeder JA; Fahs SA; Cooley BC; Chen Y; Montgomery RR; Wilcox DA; Shi Q
    J Thromb Haemost; 2012 Aug; 10(8):1570-80. PubMed ID: 22632092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term persistence of human bone marrow stromal cells transduced with factor VIII-retroviral vectors and transient production of therapeutic levels of human factor VIII in nonmyeloablated immunodeficient mice.
    Chuah MK; Van Damme A; Zwinnen H; Goovaerts I; Vanslembrouck V; Collen D; VandenDriessche T
    Hum Gene Ther; 2000 Mar; 11(5):729-38. PubMed ID: 10757352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice.
    Kikuchi J; Mimuro J; Ogata K; Tabata T; Ueda Y; Ishiwata A; Kimura K; Takano K; Madoiwa S; Mizukami H; Hanazono Y; Kume A; Hasegawa M; Ozawa K; Sakata Y
    J Gene Med; 2004 Oct; 6(10):1049-60. PubMed ID: 15386735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant factor VIII expression in hematopoietic cells following lentiviral transduction.
    Tiede A; Eder M; von Depka M; Battmer K; Luther S; Kiem HP; Ganser A; Scherr M
    Gene Ther; 2003 Oct; 10(22):1917-25. PubMed ID: 14502221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High levels of transgene expression following transduction of long-term NOD/SCID-repopulating human cells with a modified lentiviral vector.
    Gao Z; Golob J; Tanavde VM; Civin CI; Hawley RG; Cheng L
    Stem Cells; 2001; 19(3):247-59. PubMed ID: 11359950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional aspects of factor VIII expression after transplantation of genetically-modified hematopoietic stem cells for hemophilia A.
    Ide LM; Iwakoshi NN; Gangadharan B; Jobe S; Moot R; McCarty D; Doering CB; Spencer HT
    J Gene Med; 2010 Apr; 12(4):333-44. PubMed ID: 20209485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo gene therapy for hemophilia A that enhances safe delivery and sustained in vivo factor VIII expression from lentivirally engineered endothelial progenitors.
    Matsui H; Shibata M; Brown B; Labelle A; Hegadorn C; Andrews C; Hebbel RP; Galipeau J; Hough C; Lillicrap D
    Stem Cells; 2007 Oct; 25(10):2660-9. PubMed ID: 17615271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic stem cells encoding porcine factor VIII induce pro-coagulant activity in hemophilia A mice with pre-existing factor VIII immunity.
    Doering CB; Gangadharan B; Dukart HZ; Spencer HT
    Mol Ther; 2007 Jun; 15(6):1093-9. PubMed ID: 17387335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward gene therapy in haemophilia A: retrovirus-mediated transfer of a factor VIII gene into murine haematopoietic progenitor cells.
    Hoeben RC; Einerhand MP; Briët E; van Ormondt H; Valerio D; van der Eb AJ
    Thromb Haemost; 1992 Mar; 67(3):341-5. PubMed ID: 1641825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All-trans retinoic acid facilitates oncoretrovirus-mediated transduction of hematopoietic repopulating stem cells.
    Purton LE; Morris JC; Bernstein ID; Collins SJ; Kiem HP
    J Hematother Stem Cell Res; 2001 Dec; 10(6):815-25. PubMed ID: 11798508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of oncoretrovirally transduced hematopoietic stem cells and correction through ex vivo expansion.
    Bryder D; Björgvinsdóttir H; Sasaki Y; Jacobsen SE
    J Gene Med; 2005 Feb; 7(2):137-44. PubMed ID: 15538726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.